Cerebrospinal fluid complement system biomarkers in demyelinating disease

Parkinson’s Disease

Cerebrospinal fluid biomarker for Parkinson's disease: An overview

Mol Cell Neurosci.

Maass F, Schulz I, Lingor P, Mollenhauer B, Bähr M

doi: 10.1016/j.mcn.2018.12.005.

Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

JAMA Oncol.

Cheung YT, Khan RB, Liu W, Brinkman TM, Edelmann MN, Reddick WE, Pei D, Panoskaltsis-Mortari A, Srivastava D, Cheng C, Robison LL, Hudson MM, Pui CH, Krull KR

doi: 10.1001/

Aging and Cognitive FunctionsAlzheimer’s DiseaseMultiple Sclerosis

Alzheimer disease pathology and the cerebrospinal fluid proteome

Alzheimers Res Ther.

Dayon L, Núñez Galindo A, Wojcik J, Cominetti O, Corthésy J, Oikonomidi A, Henry H, Kussmann M, Migliavacca E, Severin I, Bowman GL, Popp J

doi: 10.1186/s13195-018-0397-4.

Multiple Sclerosis

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

JAMA Neurol.

van der Vuurst de Vries RM, Mescheriakova JY, Runia TF, Jafari N, Siepman TA, Hintzen RQ

doi: 10.1001/jamaneurol.

Assessing Spinal Cerebrospinal Fluid Leaks in Spontaneous Intracranial Hypotension With a Scoring System Based on Brain Magnetic Resonance Imaging Findings

doi: 10.1001/jamaneurol.

Alzheimer’s Disease

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.

JAMA Neurol.

Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C

doi: 10.1001/jamaneurol.

Multiple Sclerosis

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study

J Sleep Res.

Valko PO, Roschitzki B, Faigle W, Grossmann J, Panse C, Biro P, Dambach M, Spahn DR, Weller M, Martin R, Baumann CR

doi: 10.1111/jsr.12721.

Alzheimer’s Disease

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease

J Alzheimers Dis.

Depciuch J, Zawlik I, Skrzypa M, Pająk J, Potocka N, Łach K, Bartosik-Psujek H, Koziorowska A, Kaznowska E, Cebulski J

doi: 10.3233/JAD-

COMMENTED

Aging and Cognitive Functions

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders

JAMA Neurol.

Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K

doi: 10.1001/jamaneurol.

Related content

Cerebrospinal fluid biomarker for Parkinson's disease: An overview

Association of Cerebrospinal Fluid Biomarkers of Central Nervous System Injury With Neurocognitive and Brain Imaging Outcomes in Children Receiving Chemotherapy for Acute Lymphoblastic Leukemia

Alzheimer disease pathology and the cerebrospinal fluid proteome

Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome

Assessing Spinal Cerebrospinal Fluid Leaks in Spontaneous Intracranial Hypotension With a Scoring System Based on Brain Magnetic Resonance Imaging Findings

Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.

In search of cerebrospinal fluid biomarkers of fatigue in multiple sclerosis: A proteomics study

FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease

Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders